Iovance Biotherapeutics (IOVA) Stock Chart & Stock Price History $2.34 +0.11 (+4.93%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$2.34 0.00 (0.00%) As of 07/17/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Iovance Biotherapeutics Stock Price Performance The Iovance Biotherapeutics (IOVA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 71.84%, with a year-to-date return of -68.38%. In the past month, the stock has increased 14.71%, reflecting recent market activity. As of the latest close, Iovance Biotherapeutics traded at $2.34 with a market cap of $781.40 million and volume of 24.85 million shares. Five years ago, the stock traded at $30.61, representing a 92.36% decrease over that period. At the time, it had a market cap of $3.86 billion and a volume of 726,800 shares. Receive IOVA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+25.13%1 Month Performance+14.71%3 Month Performance-23.40%Year-To-Date Performance-68.38%1 Year Performance-71.84%5 Year Performance-92.36% IOVA Stock Chart for Friday, July, 18, 2025 IOVA Chart by TradingView Iovance Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$2.23$2.34+4.93%$2.50$2.2224.85 million shs$781.40 million07/16/2025$1.94$2.23+14.95%$2.25$1.9224.60 million shs$744.67 million07/15/2025$2.01$1.94-3.48%$1.96$1.7037.15 million shs$647.82 million07/14/2025$1.87$2.01+7.49%$2.15$1.9119.53 million shs$671.20 million07/11/2025$1.93$1.87-3.11%$1.93$1.856.77 million shs$624.45 million07/10/2025$1.99$1.93-3.02%$2.02$1.8913.53 million shs$644.49 million07/09/2025$1.77$1.99+12.43%$2.01$1.8018.78 million shs$664.53 million07/08/2025$1.70$1.77+4.12%$1.83$1.6910.56 million shs$591.06 million07/07/2025$1.75$1.70-3.08%$1.80$1.6811.04 million shs$567.68 million07/04/2025$1.75$1.75$1.78$1.734.64 million shs$585.71 million Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$1.75$1.75+0.23%$1.78$1.734.64 million shs$585.71 million07/02/2025$1.74$1.75+0.57%$1.80$1.736.75 million shs$584.38 million07/01/2025$1.72$1.74+1.16%$1.82$1.679.30 million shs$581.04 million06/30/2025$1.69$1.72+1.78%$1.77$1.707.27 million shs$574.37 million06/27/2025$1.74$1.69-2.87%$1.75$1.6617.46 million shs$564.34 million06/26/2025$1.78$1.74-2.25%$1.77$1.6912.29 million shs$581.04 million06/25/2025$1.88$1.78-5.32%$1.89$1.7311.00 million shs$594.40 million06/24/2025$1.85$1.88+1.62%$1.94$1.829.70 million shs$627.79 million06/23/2025$1.98$1.85-6.57%$1.97$1.849.06 million shs$617.77 million06/20/2025$2.04$1.98-2.94%$2.09$1.9711.21 million shs$661.18 million06/19/2025$2.04$2.04$2.10$1.958.36 million shs$681.22 million06/18/2025$2.02$2.04+0.99%$2.10$1.958.36 million shs$681.22 million06/17/2025$2.08$2.02-2.88%$2.13$2.017.85 million shs$674.55 million Related Companies Apellis Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Twist Bioscience Stock Chart Denali Therapeutics Stock Chart Kiniksa Pharmaceuticals International Stock Chart Agios Pharmaceuticals Stock Chart Vericel Stock Chart Recursion Pharmaceuticals Stock Chart CG Oncology Stock Chart Beam Therapeutics Stock Chart Receive IOVA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IOVA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
